Abivax announces temporary trading halt of its ordinary shares on Euronext Paris ...

PRESS RELEASEAB SCIENCE HAS RECEIVED APPROVAL FROM SEVERAL EUROPEAN COUNTRIES TO INITIATE THE CONFIRMATORY PHASE 3 STUDY OF MASITINIB IN AMYOTROPHIC LATERAL SCLEROSISTHIS APPROVAL FOLLOWS PROTOCOL ...

All securities to be sold in the Offering will be offered by the Company. The Company’s ADSs are listed on the Nasdaq Global Market under the ticker symbol “ABVX.” The Company’s Ordinary Shares are ...

Background Steatotic liver disease-related hepatocellular carcinoma (SLD-HCC), a rising global challenge, is characterised by ...

With few treatments available to treat Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of ...

This is a valuable study on how past sensory experiences shape perception across multiple time scales. Using a behavioural task and reanalysed EEG data, the authors identify two unifying mechanisms ...

Kickstart your clinical research journey with expert mentorship. Gain hands-on guidance, industry insights, and career ...

Background The burden of cardiovascular events in Africa is projected to rise significantly in the coming decade, placing ...

People like Big Bear Lake resident Mike Etchamendy count on clinical trials to survive. “You cut funding there, you’re going to cut major research on cancer.” ...

Ring Clear is an all-natural tinnitus supplement drawing 2025 attention in the inner ear wellness space. It combines 12 plant-based ingredients to target the neurological root cause of tinnitus, ...

Newsweek's AI Impact Award winners share how they measure success and guarantee outcomes: setting themselves apart in a crowded health tech market.

A new study by investigators from Europe, including the Netherlands and the United Kingdom (UK), has shed light on significant ethical, administrative, regulatory, and logistical (EARL) hurdles in ...